Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs Super Micro Computer Inc (SMCI) Price & Performance

Novo Nordisk A/STrade
Super Micro Computer IncTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Super Micro Computer Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Super Micro Computer Inc trades at $30.08 (market cap $15.41B). The key difference: Novo Nordisk A/S is far larger — about 14.3× Super Micro Computer Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.

NVOSMCI
Market Cap
$220.53B$15.41B
Sector
HealthTechnology
52-Week High
$71.70$60.71
52-Week Low
$35.29$20.53
Enterprise Value
$239.49B$22.93B
Dividend Yield
3.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About Super Micro Computer Inc

Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.

Read more on SMCI